Position in ASRT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$305,226
+$169,585 QoQ
Shares Held
16,014
+7.1% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASRT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Empowered Funds, LLC holds $54,609,799 across 18 Drug Manufacturers - Specialty & Generic names. ASRT ranks #13 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
20,784 | $12,324,493 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
83,971 | $11,062,337 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
276,776 | $6,255,136 | |
| 4 | PRGO |
PERRIGO Co plc
|
511,872 | $5,497,505 | |
| 5 | ZTS |
Zoetis Inc.
|
42,888 | $5,069,783 | |
| 6 | LQDA |
Liquidia Corp
|
96,717 | $3,650,099 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
181,332 | $3,552,293 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
57,384 | $1,897,688 |
All Filings in ASRT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $305,226 | 16,014 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $135,641 | 14,955 | Shares | Other | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||